Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 334

1.

Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients.

Coliche V, Sarda MN, Laville M, Chapurlat R, Rheims S, Sève P, Théry-Casari C, Lega JC, Fouque D.

Clin Kidney J. 2018 Nov 9;12(3):365-372. doi: 10.1093/ckj/sfy096. eCollection 2019 Jun.

2.

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.

Massy ZA, Caskey FJ, Finne P, Harambat J, Jager KJ, Nagler E, Stengel B, Sever MS, Vanholder R, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Soler MJ, Rychlík I, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2019 Jun 14. pii: gfz089. doi: 10.1093/ndt/gfz089. [Epub ahead of print]

PMID:
31197325
3.

Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.

Bouchet A, Teuma C, Nouvier M, Rousset P, Javaugue V, Lazareth A, Lombard C, Isaac S, Fouque D.

Am J Kidney Dis. 2019 May 30. pii: S0272-6386(19)30709-7. doi: 10.1053/j.ajkd.2019.03.426. [Epub ahead of print]

PMID:
31155325
4.

Mild cognitive impairment and kidney disease: clinical aspects.

Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutiérrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauß S, König M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlík I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G.

Nephrol Dial Transplant. 2019 Apr 9. pii: gfz051. doi: 10.1093/ndt/gfz051. [Epub ahead of print] No abstract available.

PMID:
31071220
5.

Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers.

Koppe L, Fouque D, Kalantar-Zadeh K.

J Cachexia Sarcopenia Muscle. 2019 Apr 12. doi: 10.1002/jcsm.12421. [Epub ahead of print]

6.

Erratum to Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials

Zoccali C, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Massy Z, Rychlık I, Soler MJ, Stevens K, Spasovski G, Wanner C.

Nephrol Dial Transplant. 2019 Apr 12. pii: gfz070. doi: 10.1093/ndt/gfz070. [Epub ahead of print] No abstract available.

PMID:
30977814
7.

Editorial: a new era in anti-neutrophil cytoplasmic antibody vasculitis.

Fouque D, Fervenza FC.

Nephrol Dial Transplant. 2019 Mar 1;34(3):379-381. doi: 10.1093/ndt/gfz002. No abstract available.

PMID:
30834449
8.

Erratum.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 28. pii: gfz047. doi: 10.1093/ndt/gfz047. [Epub ahead of print] No abstract available.

PMID:
30820538
9.

Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials.

Zoccali C, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Massy Z, Rychlık I, Soler MJ, Stevens K, Spasovski G, Wanner C.

Nephrol Dial Transplant. 2019 Feb 27. pii: gfz023. doi: 10.1093/ndt/gfz023. [Epub ahead of print]

PMID:
30815678
10.

A possible link between polyunsaturated fatty acids and uremic toxins from the gut microbiota in hemodialysis patients: A hypothesis.

Kemp JA, Esgalhado M, Macedo RA, Regis B, Damasceno NRT, da Silva Torres EAF, Gonçalinho GHF, Borges NA, Nakao LS, Fouque D, Mafra D.

Hemodial Int. 2019 Apr;23(2):189-197. doi: 10.1111/hdi.12725. Epub 2019 Feb 19.

PMID:
30779317
11.

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230. doi: 10.1093/ndt/gfy407.

PMID:
30753708
12.

Choosing end-stage kidney disease treatment with elderly patients: are data available?

Villain C, Fouque D.

Nephrol Dial Transplant. 2019 Jan 24. doi: 10.1093/ndt/gfy404. [Epub ahead of print] No abstract available.

PMID:
30690501
13.

Obesity phenotype and patient-reported outcomes in moderate and severe chronic kidney disease: a cross-sectional study from the CKD-REIN cohort study.

Schweitzer ML, Stengel B, Legrand K, Briançon S, Jacquelinet C, Combe C, Fouque D, Massy ZA, Laville M, Frimat L, Ayav C.

Qual Life Res. 2019 Jul;28(7):1873-1883. doi: 10.1007/s11136-019-02110-2. Epub 2019 Jan 18.

PMID:
30659448
14.

Bicarbonate Supplement Restores Urinary Klotho Excretion in Chronic Kidney Disease: A Pilot Study.

Hage V, Villain C, Pelletier S, Laville M, Drai J, Fouque D.

J Ren Nutr. 2019 Jul;29(4):285-288. doi: 10.1053/j.jrn.2018.11.001. Epub 2018 Dec 21.

PMID:
30581063
15.

Ion mobility-mass spectrometry analysis of diarylquinoline diastereomers: Drugs used for tuberculosis treatment.

Domalain V, Hubert-Roux M, Quéguiner L, Fouque DJ, Arnoult E, Speybrouck D, Guillemont J, Afonso C.

Eur J Mass Spectrom (Chichester). 2019 Jun;25(3):291-299. doi: 10.1177/1469066718813226. Epub 2018 Dec 5.

PMID:
30518251
16.

Lancet Countdown paper: what does it mean for nephrology?

Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Massy Z, Rychlík I, Soler MJ, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2019 Jan 1;34(1):4-6. doi: 10.1093/ndt/gfy369. No abstract available.

PMID:
30496519
17.

[Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia].

Hannedouche T, Fouque D, Joly D.

Nephrol Ther. 2018 Nov;14(6S):6S17-6S25. doi: 10.1016/S1769-7255(18)30647-3. Review. French.

PMID:
30473062
18.

Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients.

Bouchara A, Yi D, Pastural M, Granjon S, Selag JC, Laville M, Arkouche W, Pelletier S, Fouque D, Soulage CO, Koppe L.

Kidney Int. 2018 Nov;94(5):983-992. doi: 10.1016/j.kint.2018.07.019.

PMID:
30348306
19.

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients.

Fouque D, Roth H, Darné B, Bouchet JL, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM.

Clin Kidney J. 2018 Oct;11(5):710-719. doi: 10.1093/ckj/sfy015. Epub 2018 Mar 15.

20.

Severe tubulointerstitial nephritis: tracking tuberculosis even in the absence of renal granuloma.

Delafosse M, Teuma C, Miailhes P, Nouvier M, Rabeyrin M, Fouque D.

Clin Kidney J. 2018 Oct;11(5):667-669. doi: 10.1093/ckj/sfx157. Epub 2018 Jan 23.

21.

Low protein diets for non-diabetic adults with chronic kidney disease.

Hahn D, Hodson EM, Fouque D.

Cochrane Database Syst Rev. 2018 Oct 4;10:CD001892. doi: 10.1002/14651858.CD001892.pub4.

PMID:
30284724
22.

Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients.

Villain C, Ecochard R, Bouchet JL, Daugas E, Drueke TB, Hannedouche T, Jean G, London G, Roth H, Fouque D.

Nephrol Dial Transplant. 2019 May 1;34(5):848-858. doi: 10.1093/ndt/gfy272.

PMID:
30202988
23.

Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins.

Koppe L, Fouque D, Soulage CO.

Curr Diab Rep. 2018 Sep 8;18(10):97. doi: 10.1007/s11892-018-1064-7. Review.

PMID:
30194541
24.

Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease.

Villain C, Metzger M, Combe C, Fouque D, Frimat L, Jacquelinet C, Laville M, Briançon S, Klein J, Schanstra JP, Robinson BM, Mansencal N, Stengel B, Massy ZA; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Investigators .

Nephrol Dial Transplant. 2018 Aug 28. doi: 10.1093/ndt/gfy277. [Epub ahead of print]

PMID:
30169874
25.

The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD.

Koppe L, Fouque D.

Am J Kidney Dis. 2019 Feb;73(2):248-257. doi: 10.1053/j.ajkd.2018.06.016. Epub 2018 Aug 24.

PMID:
30149957
26.

Metformin misuse in chronic kidney disease.

Coliche V, Koppe L, Laville M, Nouvier M, Pelletier S, Trolliet P, Fouque D.

Diabetes Metab. 2018 Jul 24. pii: S1262-3636(18)30126-5. doi: 10.1016/j.diabet.2018.07.005. [Epub ahead of print] No abstract available.

PMID:
30145030
27.

Molecular Level Structure of Biodegradable Poly(Delta-Valerolactone) Obtained in the Presence of Boric Acid.

Duale K, Zięba M, Chaber P, Di Fouque DJ, Memboeuf A, Peptu C, Radecka I, Kowalczuk M, Adamus G.

Molecules. 2018 Aug 14;23(8). pii: E2034. doi: 10.3390/molecules23082034.

28.

Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.

Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Ayav C, Speyer E, Robinson BM, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Collaborators.

Br J Clin Pharmacol. 2018 Dec;84(12):2811-2823. doi: 10.1111/bcp.13738. Epub 2018 Sep 24.

PMID:
30110711
29.

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council.

Zoccali C, Arici M, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G.

Clin Kidney J. 2018 Aug;11(4):437-442. doi: 10.1093/ckj/sfy064. Epub 2018 Jul 31.

30.

Precision Medicine for Nutritional Management in End-Stage Kidney Disease and Transition to Dialysis.

Wang AY, Kalantar-Zadeh K, Fouque D, Wee PT, Kovesdy CP, Price SR, Kopple JD.

Semin Nephrol. 2018 Jul;38(4):383-396. doi: 10.1016/j.semnephrol.2018.05.008. Review.

PMID:
30082058
31.

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease.

Fouque D, Vervloet M, Ketteler M.

Drugs. 2018 Aug;78(12):1171-1186. doi: 10.1007/s40265-018-0950-2. Review.

32.

Fibroblast Growth Factor-23 Is Not a Single Bystander in Chronic Kidney Disease Mortality.

Pelletier S, Fouque D.

J Am Soc Nephrol. 2018 Oct;29(10):2601. doi: 10.1681/ASN.2018060583. Epub 2018 Jul 13. No abstract available.

PMID:
30006416
33.

ERA-EDTA invests in transformation to greener health care.

Blankestijn PJ, Arici M, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G, Zoccali C.

Nephrol Dial Transplant. 2018 Jun 1;33(6):901-903. doi: 10.1093/ndt/gfy092. No abstract available.

PMID:
29800317
34.

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council.

Zoccali C, Arici M, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1077-1082. doi: 10.1093/ndt/gfy173.

PMID:
29796635
35.

Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?

Luce M, Bouchara A, Pastural M, Granjon S, Szelag JC, Laville M, Arkouche W, Fouque D, Soulage CO, Koppe L.

Toxins (Basel). 2018 May 18;10(5). pii: E205. doi: 10.3390/toxins10050205.

36.

Very low-protein diet to postpone renal failure: Pathophysiology and clinical applications in chronic kidney disease.

Bellizzi V, Calella P, Carrero JJ, Fouque D.

Chronic Dis Transl Med. 2018 Mar 8;4(1):45-50. doi: 10.1016/j.cdtm.2018.01.003. eCollection 2018 Mar.

37.

Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) Study.

Balkau B, Metzger M, Andreelli F, Frimat L, Speyer E, Combe C, Laville M, Jacquelinet C, Briançon S, Ayav C, Massy Z, Pisoni RL, Stengel B, Fouque D.

Diabetes Metab. 2019 Apr;45(2):175-183. doi: 10.1016/j.diabet.2018.03.007. Epub 2018 Apr 6.

PMID:
29706470
38.

Aminoglycoside exposure and renal function before lung transplantation in adult cystic fibrosis patients.

Novel-Catin E, Pelletier S, Reynaud Q, Nove-Josserand R, Durupt S, Dubourg L, Durieu I, Fouque D.

Nephrol Dial Transplant. 2019 Jan 1;34(1):118-122. doi: 10.1093/ndt/gfy084.

PMID:
29684175
39.

The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease.

Koppe L, Fouque D, Soulage CO.

Toxins (Basel). 2018 Apr 13;10(4). pii: E155. doi: 10.3390/toxins10040155. Review.

40.

Risk profile, quality of life and care of patients with moderate and advanced CKD: The French CKD-REIN Cohort Study.

Stengel B, Metzger M, Combe C, Jacquelinet C, Briançon S, Ayav C, Fouque D, Laville M, Frimat L, Pascal C, Herpe YE, Morel P, Deleuze JF, Schanstra JP, Lange C, Legrand K, Speyer E, Liabeuf S, Robinson BM, Massy ZA.

Nephrol Dial Transplant. 2019 Feb 1;34(2):277-286. doi: 10.1093/ndt/gfy058.

PMID:
29635335
41.

Pro: The rationale for dietary therapy for patients with advanced chronic kidney disease.

Kopple JD, Fouque D.

Nephrol Dial Transplant. 2018 Mar 1;33(3):373-378. doi: 10.1093/ndt/gfx333.

PMID:
29471458
42.

Quel pourrait être le futur de la prise en charge de la maladie rénale chronique en nutrition ?

Fouque D.

Nephrol Ther. 2017 Jun;13(6S):6S1-6S6. doi: 10.1016/S1769-7255(18)30033-6. French.

PMID:
29463393
43.

Could Low-Protein Diet Modulate Nrf2 Pathway in Chronic Kidney Disease?

Anjos JS, Cardozo LFMF, Esgalhado M, Lindholm B, Stenvinkel P, Fouque D, Mafra D.

J Ren Nutr. 2018 Jul;28(4):229-234. doi: 10.1053/j.jrn.2017.11.005. Epub 2018 Feb 13. Review.

PMID:
29452888
44.

Establishing a clinical phenotype for cachexia in end stage kidney disease - study protocol.

Reid J, Noble HR, Adamson G, Davenport A, Farrington K, Fouque D, Kalantar-Zadeh K, Mallett J, McKeaveney C, Porter S, Seres DS, Shields J, Slee A, Witham MD, Maxwell AP.

BMC Nephrol. 2018 Feb 13;19(1):38. doi: 10.1186/s12882-018-0819-3.

45.

Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study.

Fouque D, Roth H, Darné B, Jean-Bouchet L, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM; French Phosphorus and Calcium Observatory.

Clin Kidney J. 2018 Feb;11(1):73-79. doi: 10.1093/ckj/sfx101. Epub 2017 Sep 23.

46.

Nutritional Management of Chronic Kidney Disease.

Kalantar-Zadeh K, Fouque D.

N Engl J Med. 2018 Feb 8;378(6):584-585. doi: 10.1056/NEJMc1715765. No abstract available.

PMID:
29414270
47.

The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study.

Molina P, Vizcaíno B, Molina MD, Beltrán S, González-Moya M, Mora A, Castro-Alonso C, Kanter J, Ávila AI, Górriz JL, Estañ N, Pallardó LM, Fouque D, Carrero JJ.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1223-1235. doi: 10.1093/ndt/gfx342.

PMID:
29370428
48.

Association of a Low-Protein Diet With Slower Progression of CKD.

Metzger M, Yuan WL, Haymann JP, Flamant M, Houillier P, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Bankir L, Fouque D, Stengel B.

Kidney Int Rep. 2017 Aug 30;3(1):105-114. doi: 10.1016/j.ekir.2017.08.010. eCollection 2018 Jan.

49.

Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism.

Kistler BM, Benner D, Burrowes JD, Campbell KL, Fouque D, Garibotto G, Kopple JD, Kovesdy CP, Rhee CM, Steiber A, Stenvinkel P, Ter Wee P, Teta D, Wang AYM, Kalantar-Zadeh K.

J Ren Nutr. 2018 Jan;28(1):4-12. doi: 10.1053/j.jrn.2017.10.003. Review.

PMID:
29249295
50.

Opponent's comments.

Kopple JD, Fouque D.

Nephrol Dial Transplant. 2018 Mar 1;33(3):384-387. doi: 10.1093/ndt/gfx294a. No abstract available.

PMID:
29165660

Supplemental Content

Loading ...
Support Center